Kymera Therapeutics
KYMR
#2552
Rank
ยฃ5.09 B
Marketcap
ยฃ70.77
Share price
41.55%
Change (1 day)
106.71%
Change (1 year)

Revenue for Kymera Therapeutics (KYMR)

Revenue in 2025 (TTM): ยฃ33.41 Million

According to Kymera Therapeutics's latest financial reports the company's current revenue (TTM ) is ยฃ32.82 Million. In 2024 the company made a revenue of ยฃ37.51 Million a decrease over the revenue in the year 2023 that were of ยฃ61.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Kymera Therapeutics from 2020 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) ยฃ33.41 M-10.93%
2024 ยฃ37.51 M-39.19%
2023 ยฃ61.68 M59.38%
2022 ยฃ38.7 M-28.26%
2021 ยฃ53.95 M116.1%
2020 ยฃ24.96 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA